Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 11 2024 - 7:00AM
Business Wire
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology
company discovering and developing allogeneic gamma delta T cell
therapies for autoimmune diseases and cancer, today announced that
Chen Schor, President and Chief Executive Officer, will participate
in a fireside chat at the H.C. Wainwright 2nd Annual Cell Therapy
Virtual Conference being held March 26, 2024.
Details of the event are as follows:
Date: Tuesday, March 26, 2024 Time: 10:30 a.m. ET
The live audio webcast of the presentation can be accessed on
the Investors section of Adicet Bio’s website at
http://www.adicetbio.com. An archived replay will be available for
30 days following the presentation.
About Adicet Bio, Inc.
Adicet Bio, Inc. is a clinical stage biotechnology company
discovering and developing allogeneic gamma delta T cell therapies
for autoimmune diseases and cancer. Adicet is advancing a pipeline
of “off-the-shelf” gamma delta T cells, engineered with chimeric
antigen receptors (CARs), to facilitate durable activity in
patients. For more information, please visit our website at
https://www.adicetbio.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240311201028/en/
Adicet Bio., Inc. Investor and Media Contacts
Anne Bowdidge abowdidge@adicetbio.com
Janhavi Mohite Stern Investor Relations, Inc. 212-362-1200
janhavi.mohite@sternir.com
Adicet Bio (NASDAQ:ACET)
Historical Stock Chart
From Sep 2024 to Oct 2024
Adicet Bio (NASDAQ:ACET)
Historical Stock Chart
From Oct 2023 to Oct 2024